ENDRA Life Sciences Inc. Stock News

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Yvonne Briggs - IR Francois Michelon - Chairman and CEO Mike Thornton - Chief Tech

Here's what you need to know about trading penny stocks on April 8th The post Trading Penny Stocks on April 8th? What to Know on Friday  appeared first on Penny Stocks to Buy, Picks, News and Informa

Here's what you need to know about trading penny stocks on April 8th The post Trading Penny Stocks on April 8th? What to Know on Friday  appeared first on Penny Stocks to Buy, Picks, News and Informa

ENDRA Life Sciences' (NDRA) CEO Francois Michelon on Q4 2021 Earnings Call Transcript

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NAFLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in t

Endra Life Sciences <> said the U.S. Patent and Trademark Office issued a new patent related to the company''s Thermo Acoustic Enhanced UltraSound ((TAEUS)) system.TAEUS is…

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NAFLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the European Patent Office (EPO) has issued two new patents to ENDRA, European Patent No. 3668382 (the ‘382 patent) titled “Method and System for Estimating Fractional Fat Content of an Object” and European Patent No. 3661416 (the ‘416 patent) titled “Method for Estimating Fractional Fat Content of an Object.” The ‘382 patent protects ENDRA''s meth

ENDRA Life Sciences Inc (NASDAQ: NDRA ) plans to voluntarily withdraw its 510(k) application , currently under FDA review for its TAEUS System. Instead, the Company will subsequently submit a De Novo application. TAEUS is initially focused on measuring fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Full story available on Benzinga.com

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, announces that management will present a company overview at the H.C.

Forget undervalued stocks, there is room for upside even in stocks with rising P/E.

Forget undervalued stocks, there is room for upside even in stocks with rising P/E.

ENDRA Life Sciences Inc. (NASDAQ:NDRA) with the stream of 6.79% also noticed, India Tanzanian Gold Corporation (AMEX:TRX) encountered a rapid change of -4.18% in the last hour of Thursdays trading The post Traders should follow this: ENDRA Life Sciences Inc. (NASDAQ:NDRA), Tanzanian Gold Corporation (AMEX:TRX) appeared first on Stocks Equity .

Zacks Investment Research lowered shares of ENDRA Life Sciences (NASDAQ:NDRA) from a buy rating to a hold rating in a research note issued to investors on Saturday morning, Zacks.com reports. According to Zacks, ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. []

Goldman Sachs Group Inc. acquired a new position in ENDRA Life Sciences Inc. (NASDAQ:NDRA) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 47,709 shares of the companys stock, valued at approximately $104,000. Goldman Sachs Group Inc. owned 0.11% of ENDRA Life Sciences at []